Log in to search using one of your social media accounts:

 

Mirada introduces AI software for radiation oncology
Imaging software developer Mirada Medical has introduced DLCExpert, a software...Read more on AuntMinnie.comRelated Reading: Optellum, Mirada present lung cancer study at RSNA 2017 Mirada's deep-learning contours match human-drawn contours Mirada showcases XD:PACS at RSNA 2016 Philips, Mirada sign distribution deal Mirada launches nuclear medicine software at RSNA 2015 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 21, 2018 Category: Radiology Source Type: news

SNMMI, ASNC offer guidelines for myocardial perfusion imaging with PET
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the American...Read more on AuntMinnie.comRelated Reading: SNMMI to watch for job-related health problems SNMMI names Thomas editor for technology journal SNMMI posts criteria for somatostatin receptor PET Radiologist wins ASNC's 1st clinical abstract award Medical societies expand collaboration on cardiac registry ASNC, SNMMI advise on cardiac sarcoidosis (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 13, 2018 Category: Radiology Source Type: news

SNMMI and ASNC issue joint guidelines for quantification of myocardial blood flow using PET
(Society of Nuclear Medicine and Molecular Imaging) The Society of Nuclear Medicine and Molecular Imaging's (SNMMI) Cardiovascular Council and the American Society of Nuclear Cardiology (ASNC) have issued the joint position paper, Clinical Quantification of Myocardial Blood Flow Using PET, which was jointly published in the Journal of Nuclear Cardiology and The Journal of Nuclear Medicine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 13, 2018 Category: International Medicine & Public Health Source Type: news

FDA, NRC approves RedioGenix medical isotope production from NorthStar Medical Radioisotopes
The FDA and Nuclear Regulatory Commission today approved NorthStar Medical Radioisotopes‘ RadioGenix system designed to produce Technetium-99m, which it said is the most widely used radioisotope in medical imaging. Guidance from the NRC, an independent agency created by congress to license and regulate the civilian use of radioactive materials, was issued to allow the system to produce the Tc-99m for medical purposes. With the guidance, the RadioGenix system is cleared to produce sodium pertechnetate Tc-99m to be injected intravenously, instilled into the bladder or eye or used with other FDA approved imaging drugs, ...
Source: Mass Device - February 9, 2018 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Imaging Regulatory/Compliance northstarmedicalradioisotopes Source Type: news

FDA, NRC approves RadioGenix medical isotope production from NorthStar Medical Radioisotopes
The FDA and Nuclear Regulatory Commission today approved NorthStar Medical Radioisotopes‘ RadioGenix system designed to produce Technetium-99m, which it said is the most widely used radioisotope in medical imaging. Guidance from the NRC, an independent agency created by congress to license and regulate the civilian use of radioactive materials, was issued to allow the system to produce the Tc-99m for medical purposes. With the guidance, the RadioGenix system is cleared to produce sodium pertechnetate Tc-99m to be injected intravenously, instilled into the bladder or eye or used with other FDA approved imaging drugs, ...
Source: Mass Device - February 9, 2018 Category: Medical Devices Authors: Fink Densford Tags: Food & Drug Administration (FDA) Imaging Regulatory/Compliance northstarmedicalradioisotopes Source Type: news

Study tracks radiation dose to NM technologists
A new study published February 1 in Radiology on occupational radiation...Read more on AuntMinnie.comRelated Reading: Nuclear medicine techs have higher risk of cataracts What's the radiation risk to RTs from fluoro studies? Radiologists show no radiation-related mortality risk (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 8, 2018 Category: Radiology Source Type: news

SNMMI to watch for job-related health problems
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the SNMMI...Read more on AuntMinnie.comRelated Reading: Nuclear medicine techs have higher risk of cataracts Are RTs protected enough during fluoro procedures? Cardiac cath radiation exacts toll on health personnel SIR study eyes whether radiation causes cataracts Higher cataract incidence tied to repeated head CT (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 8, 2018 Category: Radiology Source Type: news

FDA Approves Domestic Source for Tc-99m Isotopes
(MedPage Today) -- First non-uranium process for making vital nuclear medicine compounds (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - February 8, 2018 Category: American Health Source Type: news

Study tracks radiation dose to NM technologists
A new study published February 1 in Radiology on occupational radiation...Read more on AuntMinnie.comRelated Reading: Nuclear medicine techs have higher risk of cataracts What's the radiation risk to RTs from fluoro studies? Radiologists show no radiation-related mortality risk (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 8, 2018 Category: Radiology Source Type: news

Philips closes purchase of Digirad service contracts
Nuclear medicine firm Digirad has sold its Medical Device Sales and Service...Read more on AuntMinnie.comRelated Reading: Philips signs Middle East EMR deal Philips revenues climb in Q4 Philips wins Azurion order from Canadian hospital Digirad sells service contracts to Philips Digirad revenues dip, net loss widens in Q3 Digirad revenue, income fall in Q1 (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - February 5, 2018 Category: Radiology Source Type: news

PSMA PET/CT clearly differentiates prostate cancer from benign tissue
(Society of Nuclear Medicine and Molecular Imaging) Using nuclear medicine, German researchers have found a way to accurately differentiate cancerous tissue from healthy tissue in prostate cancer patients. The research is highlighted in the February issue of The Journal of Nuclear Medicine and demonstrates that the maximum standardized uptake value (SUVmax) on 68Ga-PSMA PET/CT scans correlates with PSMA-expression in primary prostate cancer. By this means, researchers were able to generate an SUVmax cutoff for the differentiation of cancerous and benign prostate tissue. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 5, 2018 Category: International Medicine & Public Health Source Type: news

PSMA PET/CT visualizes prostate cancer recurrence early, impacts radiation therapy
(Society of Nuclear Medicine and Molecular Imaging) A nuclear medicine scan may locate prostate cancer recurrence after radical prostatectomy early after disease recurrence and could help guide salvage radiotherapy, according to new research from the University of California Los Angeles (UCLA). The study, which utilizes PET/CT with gallium-68 prostate-specific membrane antigen (68Ga-PSMA-11), is documented in the featured article in the February issue of The Journal of Nuclear Medicine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - February 1, 2018 Category: International Medicine & Public Health Source Type: news

Nuclear medicine techs have higher risk of cataracts
Technologists who perform nuclear medicine exams, either diagnostic or therapeutic,...Read more on AuntMinnie.comRelated Reading: Are RTs protected enough during fluoro procedures? Cardiac cath radiation exacts toll on health personnel SIR study eyes whether radiation causes cataracts Higher cataract incidence tied to repeated head CT High cataract rates found in interventional cardiologists (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 26, 2018 Category: Radiology Source Type: news

Journal of Nuclear Medicine Technology to be covered by Clarivate Analytics
(Society of Nuclear Medicine and Molecular Imaging) The Journal of Nuclear Medicine Technology (JNMT) has been selected by Clarivate Analytics for inclusion in its Emerging Sources Citation Index. This coverage begins with 2017. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 11, 2018 Category: International Medicine & Public Health Source Type: news

Novel PET tracer clearly identifies and tracks bacterial infection in lungs
(Society of Nuclear Medicine and Molecular Imaging) Researchers at the University of Louisville, Kentucky, have demonstrated that a new radiotracer, 2-18F-fluorodeoxysorbitol (18F-FDS), can identify and track bacterial infection in lungs better than current imaging methods and is able to differentiate bacterial infection from inflammation. The study is the featured basic science article in the January issue of The Journal of Nuclear Medicine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - January 8, 2018 Category: International Medicine & Public Health Source Type: news

New appropriate use criteria for somatostatin receptor PET imaging in NETs
The Society for Nuclear Medicine and Molecular Imaging has developed and published appropriate use criteria for somatostatin PET imaging that includes different clinical scenarios for diagnosing neuroendocrine tumours.Medical Xpress (Source: Society for Endocrinology)
Source: Society for Endocrinology - January 5, 2018 Category: Endocrinology Source Type: news

SNMMI posts criteria for somatostatin receptor PET
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has released...Read more on AuntMinnie.comRelated Reading: SNMMI pushes Congress for U.S.-based Mo-99 supply SNMMI achieves policy change for wastage billing SNMMI sets AUC guidelines for malignant disease SNMMI, IAEA collaborate on training ASNC, SNMMI advise on cardiac sarcoidosis (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 5, 2018 Category: Radiology Source Type: news

SNMMI publishes appropriate use criteria for somatostatin receptor PET imaging
(Society of Nuclear Medicine and Molecular Imaging) The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has published appropriate use criteria (AUC) for somatostatin receptor PET imaging in neuroendocrine tumors. This AUC is part of a new series developed by SNMMI in its role as a qualified provider-led entity (PLE) under the Medicare Appropriate Use Criteria Program for Advanced Diagnostic Imaging. The AUC for somatostatin receptor PET imaging addresses several clinical scenarios for diagnosing neuroendocrine tumors (NETs). (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 4, 2018 Category: Cancer & Oncology Source Type: news

Medical News Today: What you should know about the HIDA scan
The HIDA scan is used to view the liver, gallbladder, bile ducts, and small intestine. Included are details on side effects and why it is done. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - January 3, 2018 Category: Consumer Health News Tags: Radiology / Nuclear Medicine Source Type: news

Digirad sells service contracts to Philips
Nuclear medicine firm Digirad has inked a definitive agreement to sell its...Read more on AuntMinnie.comRelated Reading: Royal Philips acquires IT firm Forcare Philips, Neb. hospital partner on pediatric care Philips extends partnership with Ariz. provider Digirad revenues dip, net loss widens in Q3 Digirad revenue, income fall in Q1 DMS again drives Digirad results higher (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - January 3, 2018 Category: Radiology Source Type: news

Total-body PET: Maximizing sensitivity for clinical research and patient care
(Society of Nuclear Medicine and Molecular Imaging) The new total-body PET/CT scanner could revolutionize our understanding and treatment of disease through analysis of better imaging data from the whole body. In The Journal of Nuclear Medicine featured January article, scientists at the University of California, Davis, outline the development and benefits of this innovative diagnostic tool and explain how maximizing PET sensitivity will advance clinical research and patient care. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - January 3, 2018 Category: Cancer & Oncology Source Type: news

SNMMI pushes Congress for U.S.-based Mo-99 supply
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is collaborating...Read more on AuntMinnie.comRelated Reading: SNMMI achieves policy change for wastage billing SNMMI sets AUC guidelines for malignant disease SNMMI, IAEA collaborate on training ASNC, SNMMI advise on cardiac sarcoidosis SNMMI posts use criteria for hepatobiliary scintigraphy (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 19, 2017 Category: Radiology Source Type: news

What is DIOS?
Discussion Cystic fibrosis (CF) is an autosomal recessive disorder caused by mutations in the cystic fibrosis transmembrane receptor (CFTR). It is found in the epithelium of the bronchi, intestine, pancreatic duct and biliary tree. It regulates chloride, bicarbonate and water secretion. The heterozygous state helps prevent against secretory diarrhea, but the homozygous state causes thickened secretions in the hollow tubes of the lungs and digestive tract. There are multiple mutations (> 2000) which have been currently classified into classes depending on their protein production and activity. CF patients generally are l...
Source: PediatricEducation.org - December 18, 2017 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

PET identifies which prostate cancer patients can benefit from salvage radiation treatment
(Society of Nuclear Medicine and Molecular Imaging) For prostate cancer patients who have rising levels of PSA (a cancer indicator) even after radical prostatectomy, early treatment makes a difference. In a study featured in the December issue of The Journal of Nuclear Medicine, Australian researchers demonstrate that PET scans can identify which of these prostate cancer patients would benefit from salvage radiation treatment (SRT). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - December 4, 2017 Category: International Medicine & Public Health Source Type: news

Optellum, Mirada present lung cancer study at RSNA 2017
Artificial intelligence (AI) software developer Optellum and imaging software...Read more on AuntMinnie.comRelated Reading: Mirada's deep-learning contours match human-drawn contours Optellum unveils lung cancer analysis software Mirada showcases XD:PACS at RSNA 2016 Philips, Mirada sign distribution deal Mirada launches nuclear medicine software at RSNA 2015 Former Philips CEO joins Mirada Medical (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 30, 2017 Category: Radiology Source Type: news

Bertrand Chaffee begins nuclear medicine expansion
The hospital is working on a five-year transformation plan with $11 million in state funding. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - November 29, 2017 Category: American Health Authors: Tracey Drury Source Type: news

Optellum, Mirada tout lung cancer study at RSNA 2017
Artificial intelligence (AI) software developer Optellum and imaging software...Read more on AuntMinnie.comRelated Reading: Mirada's deep-learning contours match human-drawn contours Optellum unveils lung cancer analysis software Mirada showcases XD:PACS at RSNA 2016 Philips, Mirada sign distribution deal Mirada launches nuclear medicine software at RSNA 2015 Former Philips CEO joins Mirada Medical (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - November 28, 2017 Category: Radiology Source Type: news

Droplet explosion by shock waves, relevant to nuclear medicine
(Springer) In a study published in EPJ D, Eugene Surdutovich from Oakland University, Rochester, Michigan, USA and colleagues have examined the possibility of observing the multi-fragmentation of small droplets due to shock waves initiated by ions that passed through them. The discovery of ion-induced shock waves will significantly affect our understanding of how radiation damage occurs in biomolecules due to ions. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 22, 2017 Category: Cancer & Oncology Source Type: news

Africa:Is SA 'Among the Top Six in the World' for Nuclear Medicine Ingredients?
[Africa Check] South Africa's third energy minister for 2017 has high praise for the country's nuclear capabilities. Here's what we know about South Africa's contribution to nuclear medicine. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - November 15, 2017 Category: African Health Source Type: news

A Radioactive Cloud from Russia Swept Over Europe — and No One Knows Why
A mysterious radioactive cloud that swept through much of Europe this fall has officials baffled. The cloud was harmless and has dissipated, France’s Institute for Radiological Protection and Nuclear Safety wrote in a statement Thursday, but between Sept. 27 and Oct. 13, the radioactive nuclide Ruthenium 106 was detected in “the majority of European countries.” Experts aren’t totally sure where the substance came from, though testing suggests it was first released during the last week of September in Russia or Kazakhstan, likely somewhere between Russia’s Volga River and Ural Mountains. &ldquo...
Source: TIME.com: Top Science and Health Stories - November 10, 2017 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized europe France Nuclear onetime radiaoctive Science Source Type: news

Novel nuclear medicine test can identify kidney transplant infection
(Society of Nuclear Medicine and Molecular Imaging) German scientists have developed a novel nuclear medicine test that can determine whether a kidney transplant patient has developed infection in the transplanted tissue. The study, which utilizes positron emission tomography/magnetic resonance imaging (PET/MRI), is presented in the December issue of The Journal of Nuclear Medicine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 8, 2017 Category: International Medicine & Public Health Source Type: news

Q & amp;A: How to Prepare for an AI-Driven Future
For years the role of robotics and artificial intelligence within the realm of medtech has been hyped as the future of innovation and device development. Now that technological advances are beginning to catch up to our imagination, how will advanced robotic and AI technologies begin to reshape the medtech landscape?  Srihari Yamanoor With advances in machine learning and robotic design, artificial intelligence is poised to have a dramatic impact on the medical device field. With innovative opportunities on both the diagnostic and therapeutic sides of medicine, AI technologies could be the key that unlocks...
Source: MDDI - November 7, 2017 Category: Medical Devices Authors: Kristopher Sturgis Tags: BIOMEDevice San Jose Assembly and Automation Digital Health Source Type: news

FDG PET shows tumor DNA levels in blood are linked to NSCLC aggressiveness
(Society of Nuclear Medicine and Molecular Imaging) Italian researches have demonstrated a better way of determining the aggressiveness of tumors in patients with advanced non-small cell lung cancer (NSCLC). In a study presented in the featured clinical investigation article of the November issue of The Journal of Nuclear Medicine, they used 18F-fluorodeoxyglucose (FDG) PET/CT imaging to show that the amount of cell-free tumor DNA circulating in the bloodstream correlates with tumor metabolism (linked to cancer aggressiveness), not tumor burden (amount of cancer in the body). (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 6, 2017 Category: International Medicine & Public Health Source Type: news

Persistent cramps are a symptom of colorectal cancer – but is a CURE on horizon? 
COLORECTAL cancer patients could soon benefit from a new, 100 per cent effective, nuclear medicine treatment, that doesn ’t have any side effects. (Source: Daily Express - Health)
Source: Daily Express - Health - November 3, 2017 Category: Consumer Health News Source Type: news

New system for treating colorectal cancer can lead to complete cure
In this study with a mouse model, researchers achieved a 100-percent cure rate -- without any treatment-related toxic effects. The study is reported in the November featured article in The Journal of Nuclear Medicine. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - November 2, 2017 Category: International Medicine & Public Health Source Type: news

Novartis to buy French nuclear medicine group AAA
Drugmaker to pay $3.9bn for company that specialises in radio pharmaceuticals (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - October 30, 2017 Category: Pharmaceuticals Source Type: news

SNMMI sets AUC guidelines for malignant disease
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has published...Read more on AuntMinnie.comRelated Reading: SNMMI, IAEA collaborate on training ASNC, SNMMI advise on cardiac sarcoidosis SNMMI posts use criteria for hepatobiliary scintigraphy SNMMI taps new slate of officers for 2017-2018 SNMMI partners with NDSC on appropriate use criteria (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 25, 2017 Category: Radiology Source Type: news

SNMMI, IAEA collaborate on training
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) and the International...Read more on AuntMinnie.comRelated Reading: ASNC, SNMMI advise on cardiac sarcoidosis SNMMI posts use criteria for hepatobiliary scintigraphy SNMMI taps new slate of officers for 2017-2018 ESR, IAEA partner to advance imaging IAEA debuts radiotherapy patient safety tool IAEA creates database to record R/F incidents (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 24, 2017 Category: Radiology Source Type: news

SNMMI publishes appropriate use criteria for FDG PET/CT imaging of cancer patients
(Society of Nuclear Medicine and Molecular Imaging) The Society of Nuclear Medicine and Molecular Imaging (SNMMI) has published appropriate use criteria (AUC) for FDG PET/CT in Restaging and Treatment Response Assessment of Malignant Disease. As cancer patients move through therapy, FDG PET/CT has proven an effective tool for assessing treatment response and updating the stage of malignancy. This AUC aims to improve utilization and guide providers across specialties in its use. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 24, 2017 Category: International Medicine & Public Health Source Type: news

Biodex Unveils Next Generation Atomlab 500 Dose Calibrator & Wipe...
Leader in nuclear medicine and molecular imaging solutions releases their latest Atomlab line with a sleek new design, enhanced user experience, and improved connectivity for the modern technologist...(PRWeb October 14, 2017)Read the full story at http://www.prweb.com/releases/2017/10/prweb14799264.htm (Source: PRWeb: Medical Pharmaceuticals)
Source: PRWeb: Medical Pharmaceuticals - October 14, 2017 Category: Pharmaceuticals Source Type: news

JNM articles focus on NM training requirements
Should prospective nuclear medicine (NM) clinicians learn in partnership with...Read more on AuntMinnie.comRelated Reading: SNMMI partners with NDSC on appropriate use criteria SNMMI rejects plan to dissolve ABNM SNMMI opposes proposed changes in tech duties Nuclear medicine residents see 'dismal' job market Combo residency could address nuclear medicine job woes (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - October 5, 2017 Category: Radiology Source Type: news

Novel PET tracer identifies most bacterial infections
(Society of Nuclear Medicine and Molecular Imaging) Stanford University medical scientists have developed a novel imaging agent that could be used to identify most bacterial infections. The study is the featured basic science article in The Journal of Nuclear Medicine's October issue. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 5, 2017 Category: International Medicine & Public Health Source Type: news

New targeted alpha therapy protocol for advanced prostate cancer
(Society of Nuclear Medicine and Molecular Imaging) Therapy options are limited for men with advanced-stage, metastatic castration-resistant prostate cancer, but a new treatment protocol offers hope. In the featured article of The Journal of Nuclear Medicine's October issue, German researchers report on their novel dosing regimen for actinium-225-labeled targeted alpha therapy of patients with prostate specific membrane antigen (PSMA)-positive tumors. The protocol balances treatment response with toxicity concerns to provide the most effective therapy with the least side effects. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 3, 2017 Category: Cancer & Oncology Source Type: news

What Clinical Signs Can Be Associated With Benign External Hydrocephalus?
Discussion Hydrocephalus is an abnormal accumulation of cerebrospinal fluid (CSF) in the ventricles and/or subarachnoid spaces. External hydrocephalus is a communicating hydrocephalus often defined as the patient having a rapidly enlarging head circumference (HC) and enlargement of the subarachnoid spaces especially over the frontal lobes with normal or moderately enlarged ventricles. Benign external hydrocephalus (BEH) is a self-limited external hydrocephalus that occurs during infancy and resolves spontaneously in childhood, usually by age 2 years, that is felt to not cause significant problems. It was first described by...
Source: PediatricEducation.org - October 2, 2017 Category: Pediatrics Authors: pediatriceducationmin Tags: Uncategorized Source Type: news

Mirada's deep-learning contours match human-drawn contours
Imaging software developer Mirada Medical revealed during the American Society...Read more on AuntMinnie.comRelated Reading: Mirada showcases XD:PACS at RSNA 2016 Philips, Mirada sign distribution deal Mirada launches nuclear medicine software at RSNA 2015 Former Philips CEO joins Mirada Medical Mirada, BTG develop new dosimetry software (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 25, 2017 Category: Radiology Source Type: news

Theranostics: Paintball targeting of cancer cells combined with precision therapy
(Society of Nuclear Medicine) The Journal of Nuclear Medicine's September supplement shines a spotlight on theranostics and its increasingly important role in delivering precision medicine. Theranostics refers to the combination of a predictive biomarker, identified through diagnostic imaging using radiolabeled ligands (which lock onto the specific cancer cell receptor/biomarker), with precise therapy targeted on the now-marked cancer cells. The cancer cells are destroyed, while healthy cells are unharmed -- minimizing side effects and improving quality of life for patients. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 13, 2017 Category: Cancer & Oncology Source Type: news

Double targeting ligands to identify and treat prostate cancer
(Society of Nuclear Medicine) Researchers have demonstrated a new, effective way to precisely identify and localize prostate cancer tumors while protecting healthy tissue and reducing side effects. The study is presented in the featured basic article of the September issue of the Journal of Nuclear Medicine. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 7, 2017 Category: Cancer & Oncology Source Type: news

New technique gives a clearer image of immunotherapy results in advanced brain cancer
FINDINGSResearchers led by Robert Prins, a member of the UCLA Jonsson Comprehensive Cancer Center, have developed a new approach for brain imaging that can better distinguish immune responses from tumor growth in both preclinical studies and in people with glioblastoma.BACKGROUNDDespite clinical advances in immunotherapy for cancer, non-invasive monitoring of tumor growth (especially in people with brain tumors) has been a significant problem. When clinicians use traditional medical imaging processes, the inflammation that sometimes results from immunotherapies can resemble neurological decline and tumor growth.METHODPrins...
Source: UCLA Newsroom: Health Sciences - September 5, 2017 Category: Universities & Medical Training Source Type: news

FDG-PET/CT predicts melanoma patients' response to immune checkpoint inhibitor therapy
(Society of Nuclear Medicine) Research highlighted in the featured article of the September issue of The Journal of Nuclear Medicine demonstrates that combined PET/CT scanning early in treatment of advanced melanoma could identify whether the therapy will benefit a particular patient. As the therapy has potentially serious side-effects, early determination of ineffectiveness could avert unnecessary risk exposure and provide the option of a different treatment. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - September 5, 2017 Category: Cancer & Oncology Source Type: news

SNMMI 2017-2019 Wagner-Torizuka Fellowship recipients announced
(Society of Nuclear Medicine) The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is pleased to announce the recipients of the 2017-2019 SNMMI Wagner-Torizuka Fellowship. This two-year fellowship, founded in 2008 by the late Henry N. Wagner, Jr., MD, and the late Kanji Torizuka, MD, PhD, is designed to provide extensive training and experience in the fields of nuclear medicine and molecular imaging for Japanese physicians in the early stages of their careers. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 24, 2017 Category: International Medicine & Public Health Source Type: news